Net income
-21.6 million USD
2025-07-01 – 2026-06-30
Fundies. English
SEMPER PARATUS ACQUISITION CORPORATION
EDGAR51 filing records in this dataset, filed from 2021-10-07 to 2026-08-14. Reported financial figures are available; chart coverage varies by period.
- Cash and cash equivalents
- 0 USD Source
Exact value
0 USD
- Long-term debt including current maturities
- Not available
- Shares outstanding
- 4.26 million shares Source
Exact value
4255107 shares
Reported share-count change
-97.80% · -189 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Trailing twelve months
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
Operating cash flow
-11.6 million USD
2025-07-01 – 2026-06-30
Exact inputs and evidence
- Operating cash flow: -10147310 USD · 2025-01-01 – 2025-09-30 Source
- Operating cash flow: -6497766 USD · 2025-01-01 – 2025-06-30 Source
- Operating cash flow: -12328577 USD · 2025-01-01 – 2025-12-31 Source
- Operating cash flow: -10147310 USD · 2025-01-01 – 2025-09-30 Source
- Operating cash flow: -2733769 USD · 2026-01-01 – 2026-03-31 Source
- Operating cash flow: -5739172 USD · 2026-01-01 – 2026-06-30 Source
- Operating cash flow: -2733769 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure
133 thousand USD
2023-01-01 – 2023-12-31
Exact inputs and evidence
- Capital expenditure: 133000 USD · 2023-01-01 – 2023-03-31 Source
- Capital expenditure: 133000 USD · 2023-01-01 – 2023-06-30 Source
- Capital expenditure: 133000 USD · 2023-01-01 – 2023-03-31 Source
- Capital expenditure: 133000 USD · 2023-01-01 – 2023-09-30 Source
- Capital expenditure: 133000 USD · 2023-01-01 – 2023-06-30 Source
- Capital expenditure: 133000 USD · 2023-01-01 – 2023-12-31 Source
- Capital expenditure: 133000 USD · 2023-01-01 – 2023-09-30 Source
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-08-14.
Financial data available through: 2025-12-31.
Coverage by financial measure
- revenue: No compatible figures in this window
- Operating income: 3 of 11 periods available· newest 2025-12-31
- Net income: 4 of 11 periods available· newest 2025-12-31
- Operating cash flow: 4 of 11 periods available· newest 2025-12-31
- Capital expenditure: 2 of 11 periods available· newest 2025-12-31
- Total assets: 4 of 11 periods available· newest 2025-12-31
- Total liabilities: 4 of 11 periods available· newest 2025-12-31
- Current assets: 4 of 11 periods available· newest 2025-12-31
- Current liabilities: 4 of 11 periods available· newest 2025-12-31
- Cash and cash equivalents: 4 of 11 periods available· newest 2025-12-31
- long term debt: No compatible figures in this window
- Shares outstanding: 3 of 11 periods available· newest 2025-12-31
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Net income
−USD 12.55 millionPrior period
−USD 13.73 million
–
Current period
−USD 26.28 million
–
Exact inputs and evidence
-26275432 − -13727380 = -12548052 USD
-13727380 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-26275432 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 329,847Prior period
−USD 12 million
–
Current period
−USD 12.33 million
–
Exact inputs and evidence
-12328577 − -11998730 = -329847 USD
-11998730 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-12328577 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Revenue, Capital expenditure.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
Revenue is not reported for this company, so its costs cannot be shown as a share of it.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Revenue growth
Change in revenue from the same financial period one year earlier.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Not enough comparable data to show this history.
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|
Operating cash flow
Cash generated by the company’s normal business operations.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Current assets to current liabilities
Current assets divided by current liabilities.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2022 2022-01-01 – 2022-12-31 | USD 4.41 million Exact valueExact value: 4408361 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 215,395 Exact valueExact value: -215395 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2023 2023-01-01 – 2023-12-31 | −USD 60.48 million Exact valueExact value: -60477680 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 8.17 million Exact valueExact value: -8171118 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 133,000 Exact valueExact value: 133000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 8.3 million Calculation and evidence-8171118 − 133000 USD Exact free cash flow: -8304118 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2024 2024-01-01 – 2024-12-31 | −USD 13.73 million Exact valueExact value: -13727380 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 12 million Exact valueExact value: -11998730 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2025 2025-01-01 – 2025-12-31 | −USD 26.28 million Exact valueExact value: -26275432 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 12.33 million Exact valueExact value: -12328577 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 64,439 Exact valueExact value: 64439 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 12.39 million Calculation and evidence-12328577 − 64439 USD Exact free cash flow: -12393016 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
51 filings · 1,053 latest values · 1,053 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001860871, 1860871, TVGN, TVGNW, edgar:1860871
Also known as SEMPER PARATUS ACQUISITION CORPORATION, Semper Paratus Acquisition Corp, Semper Paratus Acquisition Corporation, Tevogen Bio Holdings Inc., Tevogen Inc.